The long-anticipated merger between Germany's leading mRNA developers is now official. BioNTech SE announced late Wednesday ...
Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory ...
The "Vaccine Development Companies Landscape: Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ...
Preclinical in vivo data demonstrate hyper-precise mechanism directly targets the disease-causing mRNA repeats leading to correction of splicing ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
Moderna recently faced pressure after the U.S. Food and Drug Administration announced plans to require more rigorous safety ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...
A doctor's viral remark linking Covid virus and vaccine spike protein to a rise in rare cancers has triggered concern. But ...
Fluorogenic DNA aptamers produce light only in the correct structural state, enabling programmable molecular logic, ...
A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...
Researchers found that using mental models—visual, verbal, or animated—helps people understand mRNA vaccination science, ...
More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback